Mesenth tablets 0.25mg

Mesenth tablets 0.25mg (Siponimod fumaric acid), manufactured by Novartis Pharma (YJ code: 3999051F1024, standard: 0.25 mg 1 tablet), is a selective sphingosine-1-phosphate receptor modulator. It is used to treat relapsing forms of multiple sclerosis (MS) in adults, including active secondary progressive MS, by reducing inflammatory infiltration in the central nervous system.